Literature DB >> 21907175

Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.

Micha M M Wilhelmus1, John G J M Bol, Elise S Van Haastert, Annemieke J M Rozemuller, Guojun Bu, Benjamin Drukarch, Jeroen J M Hoozemans.   

Abstract

Parkinson's disease (PD) is characterized by α-synuclein-containing Lewy bodies (LBs) and loss of melanized neurons in the substantia nigra (SN). Recently, a link between apolipoprotein E (ApoE) expression, α-synuclein aggregation, and neurodegeneration was suggested. Here, we report on ApoE expression appearing in melanized neurons of the SN and in LBs in both PD and incidental LB disease cases. Interestingly, increased expression of the low-density lipoprotein receptor-related protein 1 (the receptor for ApoE) was also observed in incidental LB disease and PD. Our data suggest that alterations in lipoprotein homeostasis/signaling in melanized neurons of the SN are an early event during PD pathogenesis.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907175      PMCID: PMC3204035          DOI: 10.1016/j.ajpath.2011.07.021

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain.

Authors:  Micha M M Wilhelmus; Robin Verhaar; Gerda Andringa; John G J M Bol; Patrick Cras; Ling Shan; Jeroen J M Hoozemans; Benjamin Drukarch
Journal:  Brain Pathol       Date:  2010-08-20       Impact factor: 6.508

Review 2.  Alpha-synuclein, lipids and Parkinson's disease.

Authors:  Violeta Ruipérez; Frédéric Darios; Bazbek Davletov
Journal:  Prog Lipid Res       Date:  2010-05-23       Impact factor: 16.195

Review 3.  Parkinson's disease: premotor clinico-pathological correlations.

Authors:  E Ch Wolters; H Braak
Journal:  J Neural Transm Suppl       Date:  2006

4.  Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake.

Authors:  Takahisa Kanekiyo; Guojun Bu
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

Review 5.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.

Authors:  Gilbert Gallardo; Oliver M Schlüter; Thomas C Südhof
Journal:  Nat Neurosci       Date:  2008-02-24       Impact factor: 24.884

Review 7.  A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

Authors:  Kurt A Jellinger
Journal:  Biochim Biophys Acta       Date:  2008-08-05

Review 8.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.

Authors:  Guojun Bu
Journal:  Nat Rev Neurosci       Date:  2009-04-02       Impact factor: 34.870

9.  Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.

Authors:  Dennis W Dickson; Hiroshige Fujishiro; Anthony DelleDonne; Joshua Menke; Zeshan Ahmed; Kevin J Klos; Keith A Josephs; Roberta Frigerio; Melinda Burnett; Joseph E Parisi; J Eric Ahlskog
Journal:  Acta Neuropathol       Date:  2008-02-09       Impact factor: 17.088

10.  Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

Authors:  Caroline H Williams-Gray; An Goris; Misuzu Saiki; Thomas Foltynie; D Alastair S Compston; Stephen J Sawcer; Roger A Barker
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

View more
  15 in total

1.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

2.  Functional amyloids in the mouse sperm acrosome.

Authors:  Benoit Guyonnet; Nathan Egge; Gail A Cornwall
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

3.  Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

Authors:  Yu-Ting Sui; Kristin M Bullock; Michelle A Erickson; Jing Zhang; W A Banks
Journal:  Peptides       Date:  2014-09-30       Impact factor: 3.750

4.  APOE genotype regulates pathology and disease progression in synucleinopathy.

Authors:  Albert A Davis; Casey E Inman; Zachary M Wargel; Umber Dube; Brittany M Freeberg; Alexander Galluppi; Jessica N Haines; Dhruva D Dhavale; Rebecca Miller; Fahim A Choudhury; Patrick M Sullivan; Carlos Cruchaga; Joel S Perlmutter; Jason D Ulrich; Bruno A Benitez; Paul T Kotzbauer; David M Holtzman
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

5.  Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.

Authors:  Min Shi; James Movius; Romel Dator; Patrick Aro; Yanchun Zhao; Catherine Pan; Xiangmin Lin; Theo K Bammler; Tessandra Stewart; Cyrus P Zabetian; Elaine R Peskind; Shu-Ching Hu; Joseph F Quinn; Douglas R Galasko; Jing Zhang
Journal:  Mol Cell Proteomics       Date:  2015-01-02       Impact factor: 5.911

6.  Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson's Disease.

Authors:  Sanjeev Kumar Yadav; Anuj Pandey; Sana Sarkar; Smriti Singh Yadav; Devendra Parmar; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.590

7.  Global, in situ analysis of the structural proteome in individuals with Parkinson's disease to identify a new class of biomarker.

Authors:  Marie-Therese Mackmull; Luise Nagel; Fabian Sesterhenn; Jan Muntel; Jan Grossbach; Patrick Stalder; Roland Bruderer; Lukas Reiter; Wilma D J van de Berg; Natalie de Souza; Andreas Beyer; Paola Picotti
Journal:  Nat Struct Mol Biol       Date:  2022-10-12       Impact factor: 18.361

Review 8.  Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Authors:  Fatemeh Nouri Emamzadeh
Journal:  J Mol Neurosci       Date:  2017-07-10       Impact factor: 3.444

9.  Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study.

Authors:  Ashish Kumar Gupta; Komal Rani; Surabhi Swarnkar; Gaurav Khunger Kumar; Mohd Imran Khan; Ruchika Pokhriyal; Domada Ratna Kumar; Vinay Goyal; Manjari Tripathi; Rishab Gupta; Rakesh Kumar Chadda; Perumal Vanamail; Gururao Hariprasad
Journal:  J Cent Nerv Syst Dis       Date:  2018-10-09

10.  Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk.

Authors:  Lijun Zhang; Xue Wang; Ming Wang; Nick W Sterling; Guangwei Du; Mechelle M Lewis; Tao Yao; Richard B Mailman; Runze Li; Xuemei Huang
Journal:  Front Neurol       Date:  2017-09-27       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.